2026-07-29
Amcor makes flexible and rigid packaging, mostly plastic and paper based, for food, beverage, healthcare and personal care customers worldwide. Roughly 90% of earnings come from flexible packaging (pouches, films, laminates); the rest from rigid containers, largely beverage bottles. After absorbing Berry Global, Amcor is now one of the two or three largest consumer packaging companies globally, with about $22 billion of trailing revenue and 77,000 employees. The business is a low margin, high volume manufacturer whose customers are large, repeat purchasing consumer goods companies; demand is stable and non discretionary but pricing power is limited and the balance sheet now carries heavy acquisition debt.
- Intrinsic value, DCF: point estimate $25 per share (range $17 to $34, medium discount rate case)
- Intrinsic value, MEV: point estimate $50 per share (range $45 to $54)
- PE (TTM, GAAP): 30.9x, elevated because GAAP earnings are depressed by merger related amortization and integration costs. PEG: not meaningful this year given the GAAP earnings distortion.
- Forward PE (non GAAP, consensus): about 11.0x on fiscal 2026 adjusted EPS of $3.98, which is cheap if the adjusted figure is trusted and roughly fair if not.
At a Glance Scorecard
| Factor | Assessment |
|---|---|
| Business model | Simple and sustainable: yes, packaging is a necessity good with repeat demand |
| Moat | Present, narrow: scale, customer switching costs, some regulatory/food safety barriers |
| Management | Mixed: experienced operators, but a large debt funded acquisition raises capital allocation questions |
| Intrinsic value, DCF | $17 to $34 per share |
| Intrinsic value, MEV | $45 to $54 per share |
| PE / PEG | 30.9x GAAP (distorted) / 11.0x forward adjusted, PEG not meaningful |
| Price vs intrinsic value | Overvalued vs DCF by roughly 35 to 60%; near fair value to modestly undervalued vs MEV |
| Margin of safety | Negative on DCF basis, roughly 0 to 8% on MEV basis |
| Free cash flow | Weak currently: TTM FCF fell to $358 million from $810 million (FY2025), though a large part reflects one time integration and working capital costs |
| Balance sheet | Weak for now: net debt of $15.1 billion against TTM EBITDA of $2.78 billion, a net debt to EBITDA ratio of about 5.4x |
| Biggest single risk | Deleveraging fails to happen on schedule, forcing a dividend cut or a distressed asset sale |
| Buy price for 9% over 16 years | About $19 per share (see full table below) |
| Would I buy if the market closed for 5 years | No, not at the current price, given the leverage overhang |
| Snapshot verdict | Hold |
Inputs used for intrinsic value: normalized free cash flow of $1.5 billion (anchored to the 21 analyst consensus fiscal 2026 FCF estimate of $1.57 billion per stockanalysis.com, July 21, 2026), discount rate of 8.5%, terminal growth of 2.5%, 10 year explicit forecast at 3% annual FCF growth, net debt of $15.1 billion (TTM, March 2026), shares outstanding of 462.15 million, and for MEV a forward PE range of 11x to 13x applied to blended fiscal 2026/2027 consensus adjusted EPS of about $4.13.
Deep Dive
Business Understanding
Amcor designs and manufactures packaging, mostly flexible plastic and paper films, pouches and laminates, along with rigid plastic containers for beverages. Customers are large branded consumer goods companies in food, beverage, healthcare, personal care and pet care. Revenue is driven by unit volumes of packaged goods sold at the shelf, which makes underlying demand fairly stable and only mildly cyclical, since people keep buying food and medicine in a downturn. The business does not sell a finished consumer product; it sells an input, so its own pricing power depends on pass through clauses for resin costs and on how differentiated its packaging technology is. What would kill this business is not a demand collapse but a balance sheet failure: too much acquisition debt colliding with a margin squeeze, or a genuine shift away from plastic packaging that Amcor’s product mix cannot follow fast enough.
Competitive Advantage and Positioning
Amcor’s moat rests on scale, global manufacturing footprint, and the switching costs a large branded customer faces when requalifying a new packaging supplier’s specifications, especially for food safety and pharmaceutical applications. The Berry Global merger extended this scale advantage and reduced customer overlap risk. Main competitors include Sealed Air, Sonoco, Crown Holdings, Ball Corporation for rigid formats, and Smurfit WestRock in fiber based packaging. Amcor is not the pricing leader; it competes on reliability, breadth of product line, and now sheer size after the merger. Whether the moat is widening or shrinking is genuinely unclear from the data available: the merger adds scale, but scale in a commodity input business does not automatically translate into pricing power, and the resulting leverage narrows Amcor’s room to invest in premium, higher margin packaging technology relative to less indebted peers.
Financial Strength, Profitability
Pre merger, Amcor’s profitability was steady rather than growing: operating margin ran between 8.5% and 10.3% from fiscal 2021 through fiscal 2023, then slipped to 6.7% to 8.9% in fiscal 2024 and 2025 as input costs and one off items weighed on results. ROIC has followed the same pattern, falling from 9.7% in fiscal 2021 to 12.2% in fiscal 2023 (its recent high) and then down sharply to 4.4% in fiscal 2025 and 4.5% on a trailing basis, reflecting the enlarged, debt funded capital base after the merger, not necessarily a change in operating quality. This ROIC trend is the single most important number in this analysis: the merger has diluted returns on capital for now, and the investment case depends on whether cost synergies restore it toward the historical 9 to 12% range within two to three years.
Financial Strength, Balance Sheet
The balance sheet changed dramatically with the merger. Total debt rose from $7.2 billion (fiscal 2024) to $15.0 billion (fiscal 2025) to $16.7 billion (trailing, March 2026). Net debt to EBITDA sits at roughly 5.4x trailing, well above the 3 to 4x range Amcor carried before the deal and above what most investment grade packaging peers run. Goodwill and other intangibles jumped from about $6.7 billion to over $18.6 billion, standard for a large stock funded acquisition but worth flagging because it makes tangible book value deeply negative (about negative $7.0 billion). The current ratio of 1.44x and quick ratio of 0.75x are adequate for near term liquidity, but the debt load is the balance sheet’s defining feature and the main reason valuation confidence here is low rather than medium.
Financial Strength, Cash Flow
Cash flow tells a genuinely conflicting story depending on the source. Stockanalysis.com’s reported figures show FY2025 free cash flow of $810 million, down only slightly from $829 million in FY2024. Its own analyst consensus forecast table, however, shows FY2025 free cash flow of just $35 million and projects a recovery to $1.57 billion in FY2026. Trailing twelve month free cash flow (through March 2026) is reported at $358 million, well below either FY2025 figure. This is marked unverified: the discrepancy likely reflects different treatment of merger and integration cash costs, but it could not be reconciled from public summary data alone. Share count rose about 56% on a trailing basis as Berry Global shareholders received Amcor stock, which is dilution in form though it funded a real asset purchase rather than a value destroying issuance.
Margin of Safety
At $45.84, the stock sits close to or slightly above the DCF point estimate of $25, and close to or slightly below the MEV point estimate of $50. There is no comfortable margin of safety on the more conservative, cash flow based DCF measure; there is a modest one on the multiples based measure, which itself leans on non GAAP adjusted earnings that exclude real integration costs. A prudent investor should treat the effective margin of safety here as thin to negative until at least two more quarters of clean, post integration cash flow reporting are available.
Mispricing Thesis
The market’s forward PE of about 11x on consensus adjusted earnings suggests some investors see this as cheap, likely on the thesis that merger synergies will lift EBITDA and that the current 5.7% dividend yield compensates for the wait. The bear case is that “adjusted” EPS overstates true owner earnings by excluding real cash integration costs and non cash but economically real amortization of acquired customer relationships, and that the market has not yet priced the risk of a dividend cut given a payout ratio above 150% of GAAP earnings. Whether the stock is cheap or fairly priced depends almost entirely on which of these earnings measures an investor trusts, which is why this analysis assigns low confidence rather than taking a side.
Management and Capital Allocation
Management pursued a large, debt funded, stock financed acquisition rather than smaller bolt on deals or continued share buybacks, a materially different capital allocation posture than Amcor’s pre merger history of steady dividend increases and modest buybacks. That is not automatically wrong. Scale mergers in mature, low growth industries can create real value through overhead and procurement synergies, and management has publicly stated synergies are tracking ahead of plan. But the dividend has continued to grow (to $2.60 per share annualized) even as the payout ratio against GAAP earnings exceeds 150%, which is either confidence that adjusted earnings and free cash flow will soon cover it, or a sign of capital discipline stretched thin during an integration. A pending securities litigation investigation related to the Berry Global merger, noted in July 2026 news coverage, is an unresolved governance flag; it is unverified whether it will amount to anything material and is noted here as unverified.
Long-Term Outlook
In 5 to 10 years the combined company should be a larger, somewhat more diversified packaging supplier with a lower cost base if synergies are realized, competing in an industry with steady if unspectacular demand growth. Favorable trends include continued outsourcing of packaging by branded goods companies and growth in healthcare and pharmaceutical packaging. The clearest disruption risk is a genuine consumer and regulatory shift away from single use plastic packaging, which would pressure Amcor’s flexible packaging franchise over a multi year horizon; the company has invested in recyclable and fiber based alternatives but this is a real, not hypothetical, threat. In a recession, packaging demand tends to hold up better than most industrial goods since it tracks food and staples consumption, but a highly levered balance sheet leaves less room to absorb any earnings shortfall.
Risk Assessment
The dominant risk to permanent capital loss here is financial, not operational: a net debt to EBITDA ratio near 5.4x means Amcor has meaningfully less cushion than before the merger if input costs rise, synergies disappoint, or credit markets tighten. Customer concentration risk is low given a broad base of large consumer goods clients. Regulatory risk around plastics is real but slow moving. Cyclicality is modest. The scenario that would cause permanent loss of capital is a combination of slower than promised synergy capture, a soft consumer demand environment, and a subsequent credit rating pressure that forces either a dilutive equity raise or a dividend cut, both of which would reprice the stock materially lower.
Red Flag Scan
- Free cash flow has fallen sharply on a trailing basis and is inconsistently reported across sources, marked unverified.
- Debt has more than doubled and net debt to EBITDA is elevated at roughly 5.4x.
- Dividend payout ratio exceeds 150% of GAAP net income.
- ROIC has fallen from a 9 to 12% range to roughly 4.4 to 4.5%, though this partly reflects merger accounting rather than operating decay.
- Accounting complexity has increased materially with large new goodwill and intangible balances from purchase accounting.
- An unresolved securities litigation investigation tied to the merger exists, noted as unverified in scope and outcome.
No red flags were found around customer concentration or serial small acquisitions; this appears to be a single large deal rather than a pattern of empire building.
Disconfirming Evidence
The strongest case against owning Amcor here: the balance sheet is stretched at a moment when GAAP earnings, free cash flow, and ROIC are all simultaneously depressed, and the market is being asked to trust non GAAP adjusted figures that assume synergies will be realized roughly on schedule. Net debt to EBITDA near 5.4x is a level where a single disappointing quarter can trigger credit rating pressure, and a payout ratio above 150% of GAAP earnings is not sustainable indefinitely without either a real earnings recovery or a dividend cut, either of which could shake the stock’s 5.7% yield support. Free cash flow reporting inconsistency across a reputable data source is itself a signal that the post merger numbers are not yet clean enough to underwrite a high confidence valuation.
On balance, this analysis still leans toward Hold rather than Sell, because the underlying packaging business is a stable, necessity driven franchise with a plausible path to margin and ROIC recovery as integration costs roll off, and because the MEV based valuation using consensus forward earnings shows the stock roughly fairly valued rather than expensive. But the bear case is taken seriously enough that this is not a buy at the current price, and the case for trimming or avoiding new purchases is at least as strong as the case for holding.
Weighted SWOT
| Strengths | Weight | Score (1 to 10) | Weighted |
|---|---|---|---|
| Scale leader in consumer packaging post merger | 0.30 | 7 | 2.10 |
| Diversified, non discretionary end markets | 0.25 | 8 | 2.00 |
| Customer switching costs and food safety qualification barriers | 0.25 | 6 | 1.50 |
| Long dividend paying history (dividend aristocrat status) | 0.20 | 7 | 1.40 |
| Strengths total | 7.00 |
| Weaknesses | Weight | Score (1 to 10, 10 = worst) | Weighted |
|---|---|---|---|
| Net debt to EBITDA near 5.4x | 0.35 | 8 | 2.80 |
| Dividend payout ratio above 150% of GAAP earnings | 0.25 | 7 | 1.75 |
| Inconsistent, unsettled post merger financial reporting | 0.20 | 7 | 1.40 |
| Thin operating margins with limited pricing power | 0.20 | 5 | 1.00 |
| Weaknesses total | 6.95 |
| Opportunities | Weight | Score (1 to 10) | Weighted |
|---|---|---|---|
| Cost synergies from Berry Global integration | 0.35 | 7 | 2.45 |
| Deleveraging over 2 to 3 years restoring ROIC | 0.30 | 6 | 1.80 |
| Growth in healthcare and pharma packaging | 0.20 | 6 | 1.20 |
| Sustainable and recyclable packaging product lines | 0.15 | 5 | 0.75 |
| Opportunities total | 6.20 |
| Threats | Weight | Score (1 to 10, 10 = worst) | Weighted |
|---|---|---|---|
| Synergy shortfall or slower than planned deleveraging | 0.35 | 6 | 2.10 |
| Regulatory or consumer shift away from plastic packaging | 0.25 | 5 | 1.25 |
| Resin and input cost volatility | 0.20 | 5 | 1.00 |
| Pending merger related securities litigation, unverified severity | 0.20 | 4 | 0.80 |
| Threats total | 5.15 |
Net directional score (Strengths plus Opportunities minus Weaknesses minus Threats, on a comparable weighted basis): roughly neutral to slightly negative, consistent with a Hold rather than a conviction Buy or Sell.
Scenario Valuations
| Scenario | Growth assumption | Discount rate | Entry condition | Exit condition | Intrinsic value (per share) |
|---|---|---|---|---|---|
| Bear | FCF flat to 1% growth, synergies largely fail to materialize, leverage stays elevated | 10.5% | Price below $30, clear signs of credit stress | Dividend cut or covenant pressure confirmed | $5 to $17 |
| Base | FCF grows 3% annually as integration completes and modest deleveraging occurs | 8.5% | Current price near $45 | Net debt to EBITDA falls below 4x, ROIC recovers toward 7 to 8% | $17 to $34 (DCF), $45 to $54 (MEV) |
| Bull | FCF grows 5% annually, synergies exceed plan, leverage falls faster than guided | 6.5% | Price below intrinsic value with confirmed deleveraging | Net debt to EBITDA below 3x, ROIC back above 9% | $52 to $70 |
Buy Price and Margin of Safety
Buy prices below use a blended fair value anchor of $40 per share (the midpoint between the DCF and MEV base case estimates), projected forward at a 4% long run value growth assumption and discounted back to today at the stated required return. These are estimates built on the base case scenario above, not the bear or bull cases.
Table 1: Buy price for a target annual return over 16 years
| Target annual return | Buy price today |
|---|---|
| 5% | $34.32 |
| 6% | $29.49 |
| 7% | $25.38 |
| 8% | $21.87 |
| 9% | $18.87 |
| 10% | $16.30 |
Table 2: Buy price for a 9% annual return over different horizons
| Horizon | Buy price today |
|---|---|
| 5 years | $31.63 |
| 7 years | $28.79 |
| 10 years | $25.01 |
| 12 years | $22.77 |
| 14 years | $20.73 |
| 16 years | $18.87 |
At the current price of $45.84, none of these buy price targets are met. Meeting the 9% over 16 year hurdle at today’s price would require the blended fair value anchor to be closer to $97 per share, well above both the DCF and MEV estimates in this analysis.
Sell Discipline
Thesis based triggers for trimming or exiting a position, if one were held:
- Deleveraging stalls: net debt to EBITDA fails to fall meaningfully below roughly 5x within 18 to 24 months of merger close.
- Synergy targets are missed or walked back in guidance.
- ROIC does not begin recovering back toward the 7 to 9% range within two years.
- The dividend is cut, which would confirm the payout ratio concern was real rather than a temporary GAAP distortion.
- Balance sheet stress emerges: a credit rating downgrade to a level threatening investment grade status.
Valuation trigger: if the price rises well above the high end of the MEV range, roughly $54 to $60, without a corresponding improvement in leverage or free cash flow quality, that would be a signal to trim, treating it as a guide paired with the qualitative reasons above rather than a mechanical rule.
Risk and Opportunity Profile
| Risk sub-factor | Weight | Score (1 to 10, 10 = safest) | Weighted |
|---|---|---|---|
| Financial Stability | 0.30 | 4 | 1.20 |
| Earnings Volatility | 0.20 | 5 | 1.00 |
| Business Model Risk | 0.20 | 7 | 1.40 |
| Macro Sensitivity | 0.15 | 6 | 0.90 |
| Market Risk | 0.15 | 6 | 0.90 |
| Risk Score | 5.40 |
The Risk Score of 5.4 out of 10 implies moderate, leverage driven risk. Financial Stability and Earnings Volatility are the two sub-factors pulling the score down; the underlying business model itself is not particularly risky.
| Opportunity sub-factor | Weight | Score (1 to 10) | Weighted |
|---|---|---|---|
| Growth Potential | 0.30 | 5 | 1.50 |
| Unit Economics | 0.20 | 5 | 1.00 |
| Competitive Advantage | 0.20 | 6 | 1.20 |
| Valuation Asymmetry | 0.20 | 5 | 1.00 |
| Catalysts | 0.10 | 6 | 0.60 |
| Opportunity Score | 5.30 |
The Opportunity Score of 5.3 out of 10 implies a middling, unremarkable setup, roughly balanced between the deleveraging opportunity and the uncertainty over whether it plays out. Growth Potential and Valuation Asymmetry are the sub-factors most worth watching as new data arrives.
Classification
Amcor is best classified as a stable, mature business, not a growing one, whose revenue and earnings profile has been temporarily reshaped by a large acquisition rather than by organic expansion. Using Peter Lynch’s categories, it is a stalwart: a large, slow growing company whose returns will come mostly from earnings recovery, synergy capture and dividends rather than rapid growth, similar to how Lynch described mature consumer staples adjacent names. It does not fit turnaround or fast grower categories despite the current earnings distortion, since the distortion is accounting and integration driven rather than a sign of a broken core business. Using Charlie Munger’s framework, this sits closest to a fair business at a potentially fair price, and arguably drifts toward “too hard” for now, given that the true normalized earnings power of the combined company cannot yet be established with confidence from public data.
Data Used Versus Ignored
Relied upon: five years of standardized income statement, balance sheet and ratio data from stockanalysis.com (fiscal years 2021 through 2025 plus trailing twelve months through March 2026); current price, market capitalization and 52 week range as of July 29, 2026; analyst consensus price targets and adjusted EPS forecasts from S&P Global Market Intelligence via stockanalysis.com; dividend history and payout ratio; ROIC, ROE and leverage ratio trends.
Set aside: individual insider ownership and institutional holder detail was not available from the sources checked in this session and is not included; a full 10 year financial history was not accessible without a paid data subscription, so the analysis relies on the minimum 5 years the framework requires, which is a real limitation given how much the business changed mid period. The FY2025 free cash flow figure of $35 million shown in the analyst forecast table was set aside in favor of the $810 million figure shown in stockanalysis.com’s own financials pages, since the latter is presented as reported rather than modeled, but both are marked unverified pending confirmation against Amcor’s actual 10-K cash flow statement. News of a securities litigation investigation tied to the merger was noted but not weighted heavily in the valuation, since its scope and merit are unknown.
Summary and Verdict
Amcor is a stable, necessity driven packaging business that just became meaningfully larger and meaningfully more indebted through the Berry Global merger. The core franchise, scale, customer relationships, and a long dividend history, remains intact, but the financial statements available today do not yet give a clean read on normalized earnings power, and net debt to EBITDA near 5.4x leaves less room for error than Amcor carried historically. The DCF, built on actual free cash flow after debt service, points to $17 to $34 per share; the MEV, built on the market’s trusted forward adjusted earnings, points to $45 to $54 per share. At $45.84, the stock does not meet the 9% over 16 year hurdle under this analysis’s base case assumptions; it would need to trade nearer $19 to clear that bar with the same assumptions, or the underlying normalized free cash flow and deleveraging path would need to prove out meaningfully better than the base case.
Verdict: Hold. This is not a conviction sell, because the business itself looks durable and the multiples based valuation is not obviously expensive, but it is also not a buy at the current price given the DCF gap and the elevated leverage. Valuation confidence: Low, primarily due to inconsistent post merger cash flow reporting and the short track record since the deal closed. Revisit after Amcor reports fiscal 2026 fourth quarter and full year results, expected around August 12, 2026, when a full year of combined financials and clearer leverage trajectory should be available.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.